Monika Ermann, Wantage GB
Monika Ermann, Wantage GB
Patent application number | Description | Published |
---|---|---|
20100076029 | Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 03-25-2010 |
20100081644 | Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain. | 04-01-2010 |
20100261708 | Diazepane Compounds Which Modulate The CB2 Receptor - Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain. | 10-14-2010 |
20110071127 | Compounds Which Modulate the CB2 Receptor - Compounds of formula (I) | 03-24-2011 |
20110071196 | Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 03-24-2011 |
20110130431 | Compounds Which Modulate The CB2 Receptor - Compounds of formula (I) | 06-02-2011 |
20110136869 | Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 06-09-2011 |
20110190256 | Amine and Ether Compounds Which Modulate The CB2 Receptor - Compounds which modulate the CB2 receptor are disclosed. The compounds are useful for treating CB2 receptor-mediated diseases such as pain. | 08-04-2011 |
20110312932 | Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 12-22-2011 |
20120010184 | Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 01-12-2012 |
20120015988 | Sulfone Compounds Which Modulate The CB2 Receptor - Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain. | 01-19-2012 |
20120071529 | Tetrazole Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 03-22-2012 |
20120316173 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR - Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain. | 12-13-2012 |
20130184315 | SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR - Compounds of formula (I) and formula (II) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain. | 07-18-2013 |